Inducible gene expression of the human immunodeficiency virus LTR in a replication-incompetent herpes simplex virus vector
- PMID: 8941330
- DOI: 10.1006/viro.1996.0635
Inducible gene expression of the human immunodeficiency virus LTR in a replication-incompetent herpes simplex virus vector
Abstract
Although replication-incompetent herpes simplex virus (HSV) vectors have the capability to express foreign genes, successful development of these vectors for gene delivery would require that expression of the foreign gene be regulated. To investigate the feasibility of obtaining inducible expression of a foreign gene in such a vector, a replication-incompetent HSV vector, vd120/LTR beta, was developed that used the human immunodeficiency virus type 1 (HIV-1) long terminal repeat (LTR) to express the Escherichia coli lacZ gene. Examination of lacZ expression from the HIV-1 LTR in vd120/LTR beta-infected cells indicated that the LTR was active as a promoter under both replicating and nonreplicating conditions, although expression of lacZ under nonreplicating conditions was approximately 4-fold lower. In addition, the LTR expressed lacZ in a manner distinct from that of well-characterized HSV-1 promoters of each temporal class. The effect of the HIV-1 regulatory protein Tat on expression from the LTR in vd120/LTR beta was examined by infection of two different HeLa-derived cell lines that constitutively expressed Tat, HL2/3, and HLtat. Compared to infection of HeLa cells, lacZ expression from vd120/LTR beta-infected HL2/3 and HLtat cells increased from 4- to 24-fold, depending on the multiplicity of vector infection. Sustained expression of lacZ from the LTR in vd120/LTR beta-infected cells was not observed even in the continuous presence of Tat, although vector could be recovered for up to 5 days after infection. However, the amount of recoverable vector decreased during this time, suggesting that cellular cytotoxicity may account for some of the decrease in Tat-mediated expression from the LTR.
Similar articles
-
Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.Cancer Res. 2001 Apr 1;61(7):2983-95. Cancer Res. 2001. PMID: 11306477
-
Engineering cell lines for production of replication defective HSV-1 gene therapy vectors.Biotechnol Bioeng. 2009 Mar 1;102(4):1087-97. doi: 10.1002/bit.22123. Biotechnol Bioeng. 2009. PMID: 18828174
-
Highly efficient regulation of gene expression by tetracycline in a replication-defective herpes simplex viral vector.Mol Ther. 2006 Jun;13(6):1133-41. doi: 10.1016/j.ymthe.2006.01.009. Epub 2006 Mar 29. Mol Ther. 2006. PMID: 16574491
-
Replication-defective herpes simplex virus vectors for gene transfer in vivo.Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11319-20. doi: 10.1073/pnas.93.21.11319. Proc Natl Acad Sci U S A. 1996. PMID: 8876133 Free PMC article. Review. No abstract available.
-
Virus vector-mediated gene transfer.Microbiol Sci. 1987 Aug;4(8):245-50. Microbiol Sci. 1987. PMID: 3155277 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources